Semaglutide (Ozempic) is an injection originally approved by the FDA as a treatment for Type 2 diabetes
In one observational study of 69 people with obesity, the proportion reporting emotional eating dropped from 72.5% to 11.5% after three months of semaglutide ( Nicolau et al., Physiology & Behavior, 2022 )
Its not FDA approved and is illegal in many countries, including the United States
Country of Origin: South Korea Brief Description: Contains 3% Glutathione and 15.5% Niacinamide Provides antioxidant protection against free radicals Supports nutrient absorption and metabolism Brightens skin radiance and improves elasticity Enriched with vitamins B2, B6, D3, and E Suitable for all skin types Convenient daily tablet form How to use: Take one tablet daily with water
If someone living with obesity reverses their condition, they may no longer be eligible for health cover and so they, too, will come off the drug